The bactericidal activities of penicillin G and ampicillin alone were compared with those of their combinations with streptomycin or gentamicin against 17 strains of lactobacilli classified as tolerant to various fl-lactam antibiotics. The penicillin G combinations with streptomycin and gentamicin were synergistic against 17 and 16 of these strains, respectively, whereas the corresponding ampicillin-aminoglycoside combinations were synergistic against 12 and 15 strains, respectively. Importantly, synergy was manifested at concentrations of these antibiotics that are attained in serum after their administration in conventional dose regimens. In no instances were combinations antagonistic. These in vitro observations provide a partial explanation for the favorable results obtained in preliminary clinical evaluations of the benefits of combination regimens in the treatment of lactobacillus infections refractory to single-drug therapy.
The bactericidal activities of penicillin G and ampicillin alone were compared with those of their combinations with streptomycin or gentamicin against 17 strains of lactobacilli classified as tolerant to various fl-lactam antibiotics. The penicillin G combinations with streptomycin and gentamicin were synergistic against 17 and 16 of these strains, respectively, whereas the corresponding ampicillin-aminoglycoside combinations were synergistic against 12 and 15 strains, respectively. Importantly, synergy was manifested at concentrations of these antibiotics that are attained in serum after their administration in conventional dose regimens. In no instances were combinations antagonistic. These in vitro observations provide a partial explanation for the favorable results obtained in preliminary clinical evaluations of the benefits of combination regimens in the treatment of lactobacillus infections refractory to single-drug therapy.
Serious lactobacillus infections, particularly endocarditis, often result in therapeutic failure when treated with seemingly appropriate singledrug antibiotic regimens, despite readily achievable minimal inhibitory concentrations (MICs) (1, 3, 20) . Our previous studies indicated that this disparity between in vitro susceptibility data and in vivo efficacy may be partially explicable on the basis of "antibiotic tolerance" exhibited by a number of Lactobacillus strains (3) (4) (5) . The marked discrepancy between MICs and minimal bactericidal concentrations (MBCs) for individual Lactobacillus isolates (1, (3) (4) (5) and preliminary clinical evaluations suggesting efficacy of penicillin-aminoglycoside regimens in cases of refractory lactobacillus endocarditis (1, 3, 20) prompted the present study to The same inoculum was added to MH broth containing no antibiotics as a growth control. A Lactobacillus strain known to be rapidly killed by penicillin G and ampicillin at levels of l10 ,ug/ml was also included in this timed-kill assay system as a nontolerant control.
Just before incubation, a 0.01-ml portion was subcultured from each antibiotic-containing and control tube onto antibiotic-free blood agar plates as a 0-h base line; all tubes were then incubated at 37°C. At to 80/ug/ml; for streptomycin, this range was 5 to 320 ,ug/ml; and for gentamicin, the range was 0.312 to 20 ,ug/ml. These ranges were selected to encompass concentrations for each drug which are readily obtainable in serum after administration in conventional dose regimens (penicillin G-ampicillin, 510 Ag/ml; streptomycin, 520/ug/ml; gentamicin, s5 jig/ml [7, 9, 11] 17 Lactobacillus strains. Significantly, for both penicillin G and streptomycin, synergy was noted over a concentration range which is generally attainable in serum, using standard dosage regimens; for penicillin G the synergy range was 0.035 to 5 ,ug/ml, whereas for streptomycin this range was 5 to 20 jig/ml. Penicillin G-plus-gentamicin combinations were synergistically bactericidal against 16 of 17 strains at drug concentrations for each agent that are readily achievable in serum; for penicillin G the synergy range was 0.07 to 10 ,tg/ml, and for gentamicin it was 0.31 to 5 /g/ml.
Ampicillin in combination with either streptomycin or gentamicin also demonstrated excellent bactericidal activity, although somewhat less so than penicillin G-aminoglycoside combinations. Ampicillin-plus-streptomycin combinations were synergistically bactericidal against 12 of 17 isolates (70%), whereas ampicillin-plus-gentamicin combinations were synergistically bactericidal against 15 of 17 isolates (88%). For both ampicillin-aminoglycoside combinations, synergistic bactericidal activity was seen at drug concentrations which are readily achievable in serum with standard parenteral dosages of each antibiotic agent. With ampicillin-streptomycin combinations, the synergy range was 0.035 to 10 ,ug/ml for ampicillin and 5 to 20 ,jg/ml for streptomycin; with ampicillin-gentamicin combinations, the synergy range was 0.07 to 10 ,tg/ml for ampicillin and 0.31 to 5 ,ug/ml for gentamicin.
Antagonism was not observed in tolerant Lactobacillus strains not synergistically killed by the various fl-lactam-aminoglycoside combinations. These strains showed either partial synergy or indifference (Fig. 2) .
Statistical comparisons. Combinations of penicillin G plus either streptomycin or gentamicin demonstrated equal bactericidal activity. However, penicillin G-streptomycin combinations were statistically better than ampicillinstreptomycin regimens in this regard (P < 0.05).
DISCUSSION
Clinically, lactobacillemia associated with deep-seated foci, particularly endocarditis, has been relatively refractory to high-dose parenteral therapy with the penicillins, despite MICs which are readily attainable in serum (1, 13, 19, 20) . Our previous studies have demonstrated that this discrepancy between in vitro activity and suboptimal therapeutic responses in vivo may be related to antibiotic tolerance of lactobacilli to f8-lactam and other antibiotics. MBC/ MIC ratios for the lactobacilli in our previous studies have ranged from 20:1 to 30:1 for cephalothin, cefazolin, cefamandole, and cephaloridine, 62:1 for clindamycin, and 32:1 to 267:1 for penicillin G and ampicillin (3) (4) (5) (1, 3, 20) .
The present study indicates that penicillin G or ampicillin-aminoglycoside combinations also demonstrate excellent bactericidal activity in vitro against ,B-lactam-tolerant lactobacilli. Among the 17 lactobacilli tested, synergistic bactericidal activity was demonstrated in 94 to 100% of assays using penicillin G-aminoglycoside combinations. Of importance, the concentration range over which bactericidal activity occurred consistently encompassed readily achievable serum levels for both drugs in the combinations. The mechanism of the apparent superiority of penicillin G versus ampicillin in synergy testing against antibiotic-tolerant lactobacilli is not known.
A variety of single-antibiotic regimens have been efficacious in the treatment of most lactobacillus infections (3) . However, the frequent failure of these agents to cure lactobacillus endocarditis and the synergy data presented in this study indicate that penicillin-aminoglycoside 
